Is Pulmonary Embolism a Suitable Evaluation Criterion of the Efficacy of Prophylactic Treatment in Surgery?

Toulemonde, F; Doutremépuich, Christian

doi:10.1055/s-2007-1002629

Semin Thromb Hemost

1991

DOI: 10.1055/s-2007-1002629

|View full text |Cite

Is Pulmonary Embolism a Suitable Evaluation Criterion of the Efficacy of Prophylactic Treatment in Surgery?

F Toulemonde¹,

Christian Doutremépuich²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1994

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Prophylaxis for Venous Thromboembolism in Hip Fracture Surgery

Mol¹,

Egberts

1994

PharmacoEconomics

View full text Add to dashboard Cite

Fracture of the hip is one of most significant risk factors for development of deep vein thrombosis (DVT) and its complications. A number of pharmacological prophylactic methods are currently available which can reduce the incidence of postoperative thromboembolism in patients undergoing surgery for fracture of the hip. A retrospective analysis of controlled clinical studies was performed to examine in this patient group the total cost of prevention and treatment, and the cost effectiveness in terms of lives saved, of 5 prophylactic regimens--oral anticoagulants, dextran, low dose heparin, low molecular weight (LMW)-heparin and danaparoid sodium--compared with clinical diagnosis and conventional treatment of DVT only. Our results show that the total cost, including the savings in treatment of the complications of DVT, of each prophylactic regimen is less than the total cost of no prophylaxis. Thus, prophylaxis may not only save lives but may also lead to lower costs of care (including prophylaxis costs). The total cost of the new antithrombotic danaparoid sodium is less than that of the other forms of prophylaxis considered and danaparoid sodium appears to be the most cost-effective modality. We conclude that general use of danaparoid sodium in surgery for hip fracture is the most efficient approach to decreasing the incidence of postoperative morbidity and mortality and reducing healthcare expenses for the complications of DVT.

show abstract

Prophylaxis for Venous Thromboembolism in Hip Fracture Surgery

Mol¹,

Egberts

1994

PharmacoEconomics

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Is Pulmonary Embolism a Suitable Evaluation Criterion of the Efficacy of Prophylactic Treatment in Surgery?

Cited by 1 publication

References 10 publications

Prophylaxis for Venous Thromboembolism in Hip Fracture Surgery

Prophylaxis for Venous Thromboembolism in Hip Fracture Surgery

Contact Info

Product

Resources

About